View in EDS PDF Full Text

Cell‐Selective Delivery of RIBOTACs via an Anti‐EGFR Nanobody for Pancreatic Cancer Treatment.

Saved in:
Bibliographic Details
Title: Cell‐Selective Delivery of RIBOTACs via an Anti‐EGFR Nanobody for Pancreatic Cancer Treatment.
Authors: Luo, Tianli1,2 (AUTHOR), Wang, Yijuan1 (AUTHOR), Chen, Dengwang3 (AUTHOR), Zhang, Yinghan1 (AUTHOR), Shuai, Yi1 (AUTHOR), Yao, Hualiang1 (AUTHOR), Jiang, Tao1 (AUTHOR), Jiang, Hang1 (AUTHOR), Zhong, Ming1 (AUTHOR), Wang, Xiangeng1 (AUTHOR), Wang, Ziwei1 (AUTHOR), Xu, Chenchen1 (AUTHOR), Goel, Ajay4 (AUTHOR), MA, Hoi Tang2,5 (AUTHOR), Gao, Feng6 (AUTHOR), Wang, Xin1,7,8 (AUTHOR) xinwang@cuhk.edu.hk
Source: Advanced Science. Jul2026, p1. 12p. 7 Illustrations.
Database: Academic Search Ultimate
Description
ISSN:21983844
DOI:10.1002/advs.76575